Literature DB >> 19961964

Comparisons of mumps virus potency estimates obtained by 50% cell culture infective dose assay and plaque assay.

Dubravko Forcic1, Tanja Kosutić-Gulija, Maja Santak, Renata Jug, Jelena Ivancic-Jelecki, Maja Markusic, Renata Mazuran.   

Abstract

The two most commonly used methods for the determination of a virus potency are plaque assay and 50% cell culture infective dose (CCID(50)) assay, both based on cytopathic effect observation. We compared the potency estimates obtained by plaque and CCID(50) assays for nine mumps virus strains that produce different cytopathic effects in Vero cells. The ratios of CCID(50) and plaque assay quantification results differed for different strains and were in a range of 0.66-10, indicating that quantification results for some mumps virus strains are almost identical regardless of whether CCID(50) or plaque method is used, while the potency estimates of other strains strongly depend on the choice of the assay. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19961964     DOI: 10.1016/j.vaccine.2009.11.049

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Induction of IFN-α subtypes and their antiviral activity in mumps virus infection.

Authors:  Maja Markušić; Maja Šantak; Tanja Košutić-Gulija; Mladen Jergović; Renata Jug; Dubravko Forčić
Journal:  Viral Immunol       Date:  2014-12       Impact factor: 2.257

2.  Factors influencing preclinical in vivo evaluation of mumps vaccine strain immunogenicity.

Authors:  B Halassy; T Kurtović; M Brgles; M Lang Balija; D Forčić
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Stability of Minimum Essential Medium functionality despite L-glutamine decomposition.

Authors:  Maja Jagušić; Dubravko Forčić; Marija Brgles; Leonida Kutle; Maja Šantak; Mladen Jergović; Ljerka Kotarski; Krešo Bendelja; Beata Halassy
Journal:  Cytotechnology       Date:  2015-04-24       Impact factor: 2.058

4.  Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.

Authors:  M Šantak; M Lang-Balija; J Ivancic-Jelecki; T Košutić-Gulija; S Ljubin-Sternak; D Forcic
Journal:  Epidemiol Infect       Date:  2012-09-07       Impact factor: 4.434

5.  Easy and Rapid Detection of Mumps Virus by Live Fluorescent Visualization of Virus-Infected Cells.

Authors:  Tadanobu Takahashi; Takashi Agarikuchi; Yuuki Kurebayashi; Nona Shibahara; Chihiro Suzuki; Akiko Kishikawa; Keijo Fukushima; Maiko Takano; Fumie Suzuki; Hirohisa Wada; Tadamune Otsubo; Kiyoshi Ikeda; Akira Minami; Takashi Suzuki
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

6.  Mass spectrometry-based investigation of measles and mumps virus proteome.

Authors:  Dora Sviben; Dubravko Forcic; Beata Halassy; Günter Allmaier; Martina Marchetti-Deschmann; Marija Brgles
Journal:  Virol J       Date:  2018-10-16       Impact factor: 4.099

7.  Production- and Purification-Relevant Properties of Human and Murine Cytomegalovirus.

Authors:  Sanda Ravlić; Marija Brgles; Lea Hiršl; Stipan Jonjić; Beata Halassy
Journal:  Viruses       Date:  2021-12-10       Impact factor: 5.048

8.  Population Variability Generated during Rescue Process and Passaging of Recombinant Mumps Viruses.

Authors:  Anamarija Slović; Tanja Košutić-Gulija; Dubravko Forčić; Maja Šantak; Maja Jagušić; Mirna Jurković; Dorotea Pali; Jelena Ivančić-Jelečki
Journal:  Viruses       Date:  2021-12-20       Impact factor: 5.048

9.  Detection of replication-defective hepatitis A virus based on the correlation between real-time polymerase chain reaction and ELISA in situ results.

Authors:  Alyne Moraes Costa; Luciane Almeida Amado; Vanessa Salete de Paula
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-02       Impact factor: 2.743

10.  Multiplex PCR-based titration (MPBT) assay for determination of infectious titers of the three Sabin strains of live poliovirus vaccine.

Authors:  Hasmik Manukyan; Elvira Rodionova; Tatiana Zagorodnyaya; Tsai-Lien Lin; Konstantin Chumakov; Majid Laassri
Journal:  Virol J       Date:  2019-10-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.